Rhinostop tablete
| Name | Rhinostop tablete |
|---|---|
| Marketing Authorisation Number | HR-H-369539634 |
| Active Substance | paracetamol pseudoefedrinklorid klorfenaminmaleat |
| Composition | jedna tableta sadrži 251,00 mg paracetamola, 61,20 mg pseudoefedrinklorida i 2,54 mg klorfenaminmaleata |
| Pharmaceutical Form | tableta |
| Packaging [MA Number for Packaging] | 10 tableta u blisteru, u kutiji [HR-H-369539634-01] |
| Manufacturer | Jadran Galenski laboratorij d.d., Rijeka, Hrvatska |
| Marketing Authorisation Holder | Bosnalijek d.o.o., Gruška 18, Zagreb, Hrvatska |
| Marketing Authorisation Date | 30.01.2019 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/17-02/107 |
| Registration Number | 381-12-01/38-19-08 |
| Prescription | bez recepta |
| Distribution | u ljekarni |
| Advertising to general public | dopušteno |
| ATC Code | N02BE51 |
| Medicinal product marketed in the Croatia | Da |
| SmPC | download |
| PL | download |
Direct Healthcare Professional Communication
| Name | Date | Download |
|---|---|---|
| Pismo zdravstvenim radnicima o riziku od sindroma posteriorne reverzibilne encefalopatije i sindroma reverzibilne cerebralne vazokonstrikcije uz primjenu lijekova koji sadrže pseudoefedrin | 09.02.2024 | Alkaloid d.o.o., Bayer d.o.o., Pliva Hrvatska d.o.o., Reckitt Benckiser d.o.o., Krka - farma d.o.o., Bosnalijek d.o.o., Jadran Galenski laboratorij d.d. |
